Cercare Medical develops the CMN software platform that produces advanced perfusion maps for both CT and MRI, with proprietary biomarkers and fully automated, multi-vendor compatible post-processing. The platform is used to assess brain tissue pathologies across stroke, oncology, Alzheimer’s, dementia and COVID-19. The company reports yearly triple-digit growth and has been adopted by prominent stroke and oncology facilities in more than 23 countries. Leadership includes Jeppe Øvlesen (Chairman) and Kim Mouridsen (CEO). Cercare is deepening collaborations with partners such as Microsoft, Siemens, Blackford, Aidoc, SECTRA, TeraRecon and Viz.AI. The company plans to use the new funding to expand operations in the United States, the UK and selected European countries.

Total raised

$9M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2025